Pourquoi et comment innover aujourd'hui ? - 2026-27 (2)

Pourquoi et comment innover aujourd'hui ? - 2026-27 (2)

Why and how to innovate today? - 2026-27 (2)

Title history
  • Pourquoi et comment innover aujourd'hui ? - 2026-27 (2) — observed on 20261026-1551 UTC (YouTube)

by Pierre Corvol · View the channel on PSI

Humanities, Social Sciences & Thought Science — General & History PDScience: general issuesPDGIndustrial applications of scientific research and technological innovation
🎙 Pierre Corvol 👥 152K 📅 October 26, 2026 ⏱ 12 min 👁 7 📄 expert opinion 🧭 2026-10-26
Available in: English (current) Français

Keywords

innovationresearchbiotechacademiatechnology transfer

Summary

The video is a lecture by Professor Pierre Corvol, former administrator of the Collège de France, introducing a symposium on innovation. He argues that innovation is now seen as a key driver of economic and social progress, but this was not always the case in academia. Corvol cites Didier Raoult’s distinction between discovery, invention, and innovation, emphasizing the non-linear nature of the process. He recounts the creation of the Liliane Bettencourt Chair of Technological Innovation at the Collège de France in 2006, highlighting its role in promoting interdisciplinary research and industry-academia dialogue. Two illustrative case studies are presented: Jean-Paul Clozel, who co-founded Actelion after discovering the drug bosentan for pulmonary arterial hypertension, and Elias Zerhouni, former NIH director who taught on 4P medicine (predictive, preventive, personalized, participatory). The lecture concludes with a reflection on the ethical implications of biomedical progress, noting that ethics often lags behind science. Corvol frames the chair’s impact on thousands of listeners and the importance of supporting innovative researchers.

163 words

Critical Evaluation

Value of the Information & Strength of the Argument

The information value is substantial, grounded in the speaker’s personal experience as a physician-scientist and former administrator. The argumentation is structured around concrete examples (Clozel, Zerhouni) that illustrate the journey from research to innovation, including obstacles such as the initial lack of interest from pharmaceutical companies like Hoffmann-La Roche. Corvol emphasizes the non-linear nature of innovation, countering the simplistic ‘from bench to market’ narrative, and provides insights into institutional support mechanisms. The reasoning is clear and persuasive, although somewhat reliant on anecdotal evidence rather than systematic data.

96 words

Title / Content Match

The title accurately reflects the content: an introductory reflection on the rationale and methods of innovation.

Quality & Reliability

8/10

Talk by a renowned professor at Collège de France, drawing on personal experience and documented case studies; high credibility, but the short format limits depth.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

External References

Contribution & Novelties

The lecture offers a retrospective on institutional innovation support at a major academic institution, providing anecdotal yet valuable insights into the challenges of translating research into products, such as the bosentan case. Its novelty lies in the personal perspective of a key figure in French academic leadership.

Pour aller plus loin :

  • Optogenetics — Central to the Deisseroth and Nagel work discussed; relevant for understanding the highlighted innovation.
  • Actelion — The biotech company founded by the Clozels, illustrating the startup journey from academic research.
  • P4 Medicine — Concept promoted by Zerhouni; broadens the scope to predictive, preventive, participatory medicine.
  • Innovation — General framework distinguishing types and processes of innovation, relevant to Raoult’s taxonomy.

113 words

Radar Profile

Reliability 8/10